活血化瘀法治疗川崎病用药规律挖掘及起效机制研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.4

基金项目:

广东省中医药局科研项目(20212060)


Study on Medication Rules and Effective Mechanism of Blood-Invigorating and Stasis-Dissolving Method in Treating Kawasaki Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:基于数据挖掘和网络药理学研究活血化瘀中药治疗川崎病的用药规律及起效机制,为活血 化瘀法治疗川崎病提供进一步的依据。方法:于中英文八大数据库中搜索活血化瘀中药治疗川崎病文献,整理 文献,进行频次与四气五味分析,并运用SPSS与R studio进一步挖掘用药规律。对得到的核心组方进行网络药 理学分析,并运用分子对接进行验证。结果:共筛选出48首活血化瘀中药治疗川崎病的有效方,其中包含 96味中药。使用频率最高的依次为地黄、连翘、赤芍、石膏等。其中药味主要集中在甘和苦;归经主要集中 在肺经和肝经。配伍分析和聚类分析得到玄参、地黄、连翘、淡竹叶、金银花和牡丹皮是活血化瘀法治疗川崎 病核心药组。网络药理学结果显示,核心药组的关键靶点包括TNF、AKT1、IL-6、TP53、MAPK14等,涉及 主要通路包括流体剪切应力与动脉硬化、脂质与动脉粥样硬化等。分子对接结果表明核心组方的活性成分与关 键靶点能够较好的结合。结论:活血化瘀法治疗川崎病的高频药物以地黄、赤芍、水牛角及玄参等中药为主, 治疗川崎病的核心药物有玄参、地黄、连翘、淡竹叶、金银花和牡丹皮,涉及多靶点多通路。

    Abstract:

    Objective: Based on data mining and network pharmacology, the medication rules and effective mechanism of Chinese medicinals for invigorating blood and dissolving stasis in treating Kawasaki disease were studied, so as to provide further basis for using blood-invigorating and stasis-dissolving method to treat Kawasaki disease. Methods:Literatures on using Chinese medicinals for invigorating blood and dissolving stasis to treat Kawasaki disease were searched from eight databases in Chinese and English. The literatures were sorted out and analyzed for frequency, four qi and five flavors, and the medication rules were further explored by SPSS and R studio. The obtained core combinations were analyzed by network pharmacology and verified by molecular docking. Results: A total of 48 pieces of effective prescriptions involving Chinese medicinals for invigorating blood and dissolving stasis for treating Kawasaki disease were screened out,including 96 kinds of Chinese medicinals. The most frequently used ones were Rehmanniae Radix,Forsythiae Fructus,Paeoniae Radix Rubra,and Gypsum Fibrosum. Among them,the medicinal flavors were mainly sweet and bitter;the channel entries were mainly the lung and liver channels. Compatibility analysis and cluster analysis showed that Scrophulariae Radix, Rehmanniae Radix, Fructus Forsythiae, Lophatheri Herba, Lonicerae Japonicae Flos and Moutan Cortex were the core medicinal combinations in using Chinese medicinals for invigorating blood and dissolving stasis to treat Kawasaki disease. Network pharmacology results showed that the key targets of the core medicinal combinations included TNF, AKT1, IL-6,TP53,MAPK14,etc.,which involved major pathways including fluid shear stress and arteriosclerosis and lipid and atherosclerosis. The results of molecular docking showed that the active components of the core combinations could combine well with the key targets. Conclusion:In using Chinese medicinals for invigorating blood and dissolving stasis to treat Kawasaki disease, the main highfrequency Chinese medicinals are Rehmanniae Radix, Paeoniae Rubra Radix, Bubali Cornu and Scrophulariae Radix;the core Chinese medicinals are Scrophulariae Radix,Rehmanniae Radix,Forsythiae Fructus, Lophatheri Herba, Lonicerae Japonicae Flos and Moutan Cortex, involving multiple targets and multiple pathways.

    参考文献
    相似文献
    引证文献
引用本文

区秀汝,麦绮琪,陈正义,王澄槟,周娟,赖东兰.活血化瘀法治疗川崎病用药规律挖掘及起效机制研究[J].新中医,2024,56(21):1-9

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-11-11
  • 出版日期:
文章二维码